1Mozzetti S,Ferlini C,Concolino P,et al.Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients[J].Clin Cancer Res,2005,11(1):298-305.
2Kennedy RD,Quinn JE,Mullan PB,et al.The role of BRCA1 in the cellular response to chemotherapy[J].J Natl Cancer Inst,2004,96(22):1659-1668.
3Tarapore P,Fukasawa K.Loss of p53 and centrosome hyperamplification[J].Oncogene,2002,21(40):6234-6240.
4Kramer A,Lukas J,Bartek J.Checking out the centrosome[J].CELLCYCLE,2004,3(11):1390-1393.
5Kin R,Emi M,Tanabe K,et al.Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy[J].Cancer,2004,101(11):2491-2502.
8Mazieres J,Pradines A,Favie G,et al.Perspetcives on famesyl transferase inhibitors in cancer therapy[J].Cancer Lett,2004,206(2):159-167.
9Rojo F,Najere L,ECT AL.4E-binding protein 1,a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis[J].Clin Cancer Res,2007,13(1):81-89.
10Huang S,Bjornstim A,Hou GJ.Rapamycins:mechanism of action and cellular resistance[J].Cancer Biol Ther,2003,2 (3):222-232.
二级参考文献29
1[1]RHOADS R E.Regulation of eukaryotic protein synthesis by initiation factors[J].J Biol Chem,1993,268 (5):3017-3021.
2[2]GINGRAS A C,RAUGHT B,SONENBERG N.Regulation of translation initiation by FRAP/mTOR[J].Genes Dev,2001,15(7):807-826.
3[3]LIVOLSI V,MAZZAFERRI E,SCHNEIDER A,et al.Papillary carcinom[M]//Ronald A,Ricardo V,Philip U.Pathology and genetics of tumors of endocrine organs.Lyon:IARC Press,2004:57-66.
4[4]LEE J W,CHOI J J,LEE K M,et al.eIF4E expression is associated with histopathologic grades in cervical neoplasia[J].Hum Pathol,2005,36(11):1197-1203.
5[5]DE BENEDETTI A,GRAFF J R.eIF4E expression and its role in malignancies and metastases[J] Oncogene,2004,23(18):3189-3199.
6[6]WANG S,LLOYD R V,HUTZLER M J,et al.Expression of eukaryotic translation initiation factors 4E and alpha correlates with the progression of thyroid carcinoma[J].Thyroid,2001,11 (12):1101-1107.
7[7]KEREKATTE V,SMILEY K,HU B,et al.The proto-oncogene/translation factor eIF4E:a survey of its expression in breast carcinomas[J].Int J Cancer,1995,64(1):27-31.
8[8]CREW J P,FUGGLE S,BICKNELL R,et al.Eukaryotic initiation factor 4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumor progression[J].Br J Cancer,2000,82(1):161-166.
9[9]HUANG S,BJORNSTI M A,HOUGHTON P J.Rapamycins:mechanism of action and cellular resistance[J].Cancer Biol Ther,2003,2(3):222-232.
10Penson RT, Oliva E, Skates SJ, et al. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol,2004,93(1):98-106.
2Zhang YJ, Dai Q, Sun DF, et al. mTOR signaling pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol, 2009,16(9) :2617-2628.
3Hay N,Sonenberg N. Upstream and downstream of mTOR. Genes Dev, 2004, 18(16) :1926-1945.
4Proud CG. Regulation of mammalian translation factors by nutri- ents. Eur J Biochem, 2002, 269(22) :5338-5349.
5Castellvi J, Garcia A, Ruiz-Marcellan C, et al. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 ex- pression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol,2009, 40 (10) : 1418-1426.
6Herbert TP, Tee AR, Proud CG. The Extracellular Signal-regula- ted Kinase Pathway Regulates the Phosphorylation of 4E-BP1 at Multiple Sites. J Biol Chem , 2002,277 ( 13 ) : 11591-11596.
7O' Reilly KE, Warycha M, Davies MA, et al. Phosphorylated 4E- BP1 is associated with poor survival in melanoma. Clin Cancer Res, 2009, 15(8) :2872-2878.
8Armengol G, Rojo F, Castellvl J,et al. E-binding protein 1 : a key molecular "funnel factor" in human cancer with clinical implica- tions. Cancer Res,2007,67(16) :7551-7555.
9Rojo F, Najera L, Lirola J, et al. 4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis. Clin Cancer Res, 2007, 13 (1) :81-89.
10Castellvi J, Gareia A, Rojo F, et al. Phosphorylated 4E binding protein 1 : A hallmark of cell Signaling that correlates with surviv- al in ovarian cancer. Cancer, 2006, 107(8) :1801-1811.
